277 related articles for article (PubMed ID: 32305537)
1. Soluble ST2: A complex and diverse role in several diseases.
Homsak E; Gruson D
Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537
[TBL] [Abstract][Full Text] [Related]
2. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2--analytical considerations.
Mueller T; Jaffe AS
Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
[TBL] [Abstract][Full Text] [Related]
4. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
5. The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation.
Brunetti G; Barile B; Nicchia GP; Onorati F; Luciani GB; Galeone A
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371771
[TBL] [Abstract][Full Text] [Related]
6. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
7. Soluble ST2 in heart failure.
Dieplinger B; Mueller T
Clin Chim Acta; 2015 Mar; 443():57-70. PubMed ID: 25269091
[TBL] [Abstract][Full Text] [Related]
8. The biology of ST2: the International ST2 Consensus Panel.
Pascual-Figal DA; Januzzi JL
Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Production of Soluble ST2 in Heart Failure.
Pascual-Figal DA; Pérez-Martínez MT; Asensio-Lopez MC; Sanchez-Más J; García-García ME; Martinez CM; Lencina M; Jara R; Januzzi JL; Lax A
Circ Heart Fail; 2018 Dec; 11(12):e005488. PubMed ID: 30562096
[TBL] [Abstract][Full Text] [Related]
10. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
[TBL] [Abstract][Full Text] [Related]
11. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.
Januzzi JL; Mebazaa A; Di Somma S
Am J Cardiol; 2015 Apr; 115(7 Suppl):26B-31B. PubMed ID: 25665762
[TBL] [Abstract][Full Text] [Related]
12. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
Tan YJ; Siow I; Saffari SE; Ting SKS; Li Z; Kandiah N; Tan LCS; Tan EK; Ng ASL
J Alzheimers Dis; 2023; 92(2):573-580. PubMed ID: 36776067
[TBL] [Abstract][Full Text] [Related]
13. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
[TBL] [Abstract][Full Text] [Related]
14. IL-13 Controls IL-33 Activity through Modulation of ST2.
Zhang M; Duffen JL; Nocka KH; Kasaian MT
J Immunol; 2021 Dec; 207(12):3070-3080. PubMed ID: 34789557
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-33 and Soluble ST2 Levels in Infants with Hypoxic-Ischemic Encephalopathy.
Hamano H; Takahashi K; Kimura S; Matsuguma C; Kaneyasu H; Fujimoto Y; Ohta N; Okada S; Hasegawa S
Neonatology; 2023; 120(3):353-362. PubMed ID: 36996771
[TBL] [Abstract][Full Text] [Related]
16. ST2: a novel biomarker for heart failure.
Bhardwaj A; Januzzi JL
Expert Rev Mol Diagn; 2010 May; 10(4):459-64. PubMed ID: 20465500
[TBL] [Abstract][Full Text] [Related]
17. [The physiologic and pathophysiologic role of stimulating growth factor ST2.].
Dyleva YA; Gruzdeva OV; Akbasheva OE; Uchasova EG; Barbarash OL
Klin Lab Diagn; 2017; 62(10):599-605. PubMed ID: 30821940
[TBL] [Abstract][Full Text] [Related]
18. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
[TBL] [Abstract][Full Text] [Related]
19. ST2/IL-33 signaling in cardiac fibrosis.
Vianello E; Dozio E; Tacchini L; Frati L; Corsi Romanelli MM
Int J Biochem Cell Biol; 2019 Nov; 116():105619. PubMed ID: 31561019
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis.
Zhang Y; Cheng B; Wu ZW; Cui ZC; Song YD; Chen SY; Liu YN; Zhu CJ
World J Gastroenterol; 2021 Oct; 27(38):6489-6500. PubMed ID: 34720537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]